Clinical Research Directory
Browse clinical research sites, groups, and studies.
Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke With Occlusion of the M2 Segment of Middle Cerebral Artery
Sponsor: Hyogo Medical University
Summary
RESCUE-M2O trial is a prospective, open label, blinded endpoint (PROBE), two-arm, randomized, controlled, post-market study to assess the efficacy and safety of endovascular therapy for acute ischemic stroke with occlusion of the M2 segment of the middle cerebral artery.
Official title: Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke With Occlusion of the M2 Segment of Middle Cerebral Artery (the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism-M2 Occlusion Trial: RESCUE-M2O Trial)
Key Details
Gender
All
Age Range
18 Years - 84 Years
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2025-12-01
Completion Date
2030-03-31
Last Updated
2026-02-24
Healthy Volunteers
No
Conditions
Interventions
Endovascular therapy
Endovascular therapy for acute ischemic stroke with occlusion of the M2 segment of the middle cerebral artery.
Locations (2)
Hyogo Medical University
Nishinomiya, Hyōgo, Japan
Hyogo Medical University
Nishinomiya, Hyōgo, Japan